Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Trial of Ibrutinib plus Brentuximab Vedotin in Relapsed/Refractory Hodgkin Lymphoma

Protocol: OSU-18084

Full Title

A Multi-Center Phase II Trial of Ibrutinib plus Brentuximab Vedotin in Relapsed/Refractory Hodgkin Lymphoma

Lymphoma Hodgkin’s Lymphoma